Matrix effect during study sample analysis [Bioanalytics]

posted by ElMaestro  – Denmark, 2020-04-09 08:40 (284 d 02:56 ago) – Posting: # 21321
Views: 1,175

Hello shreyas goswami,


» No matrix effect observed during method development and method validation but what if matrix effect observed during subject sample analysis. ISTD {labelled IS} response difference in subject sample and CC/QC sample is found more than 40 percent. Moreover CC/QC samples were interspersed with subject samples and entire batch was processed in single processing batch.

A trillion billion years ago, when companies used to buy citrate plasma from blood banks to use for QCs and calibrators, while they were using Heparin or K2EDTA tubes etc for the PK samples, this effect was seen. It could go in both directions (enhancement, suppression). I believe companies learned that regulators were not, to say the least, supporting that practice with much enthusiasm :-D

» Do we need to conduct further analysis with proper investigation and what if matrix effect observed due to change in population matrix.

There are no clear rules stated anywhere what to do, but it sounds like your QC + calibrator matrix has some properties that differ from that of your samples, and some degree of investigation would be a good idea.
Can you show the data or an IS plot?

» Does this data accepted by regulatory agencies.:confused:

If they notice it then they are in their good right to raise a lot of questions. And they might do so.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 8 (2 registered, 6 guests [including 3 identified bots]).
Forum time: Monday 10:37 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5